Reversal of severe hypertriglyceridemia with intermittent fasting and a very-low-carbohydrate ketogenic diet: a case series
Authors:
- 27 July 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 27 (5) , 308-311
Abstract
Purpose of review To illustrate successful reversal of hypertriglyceridemia using a very-low-carbohydrate ketogenic diet in conjunction with intermittent fasting in two patients. Recent findings Hypertriglyceridemia remains an important component of residual risk for atherosclerotic cardiovascular disease. Current guidelines from the AHA/ACC recommend the initiation of a very-low-fat diet to treat persistently elevated triglycerides, whereas the National Lipid Association argues that a very-low-carbohydrate, high-fat diet is contraindicated in severe hypertriglyceridemia. In contrast, we report resolution of two cases of severe hypertriglyceridemia with implementation of very-low-carbohydrate ketogenic diets and intermittent fasting. Summary Here, we describe two patients who have demonstrated substantial reductions in serum triglycerides, effectively reversing severe hypertriglyceridemia using unconventional dietary methods. Although anecdotal, these cases point to a critical lack of flexibility in current dietary guidelines that hinder their application in clinical practice.Keywords
This publication has 16 references indexed in Scilit:
- The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and futureProgress in Cardiovascular Diseases, 2019
- Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task ForceJournal of Clinical Lipidology, 2019
- Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based studyEuropean Heart Journal, 2017
- Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular DiseaseJACC, 2014
- Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults—Invited CommentaryArchives of internal medicine (1960), 2009
- Fenofibrate: treatment of hyperlipidemia and beyondExpert Review of Cardiovascular Therapy, 2008
- HypertriglyceridemiaNew England Journal of Medicine, 2007
- Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media ThicknessCirculation, 1997
- Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Triglyceride-rich lipoproteins and the progression of coronary artery diseaseCurrent Opinion in Lipidology, 1995